BRIEF-Threshold Pharmaceuticals and Molecular Templates agree to combine

Fri Mar 17, 2017 11:26am GMT

March 17 (Reuters) - Threshold Pharmaceuticals Inc

* Threshold Pharmaceuticals and Molecular Templates agree to combine

* Threshold Pharmaceuticals Inc says combined company will be capitalized to support advancement of MT-3724

* Longitude Capital will invest $20 million at close of transaction

* Threshold Pharmaceuticals Inc says transaction has been approved by board of directors of both companies

* Threshold Pharma - concurrent with execution of merger agreement, Threshold made a bridge loan to Molecular Templates in principal amount of $2 million.

* Threshold Pharmaceuticals - Molecular Templates shareholders would own about 65.6 percent of combined company

* Threshold - on pro forma basis & based upon number of shares to be issued in deal, current threshold shareholders would own about 34.4 percent of combined co

* Threshold Pharmaceuticals - in event that transaction does not close by May 31, 2017, co agreed to make available further funding of up to $2 million   Continued...

Powered by Reuters AlertNet. AlertNet provides news, images and insight from the world's disasters and conflicts and is brought to you by Reuters Foundation.